Registered number: 14402486

Urimpex Ltd
Unaudited Financial Statements
for the year ended 02 August 2024

Statement of Financial Position

as at 02 August 2024

  2024
2023
   
££
 
££
Called up share capital not paid  
  -  
 
  -  
Fixed assets  
  -  
 
  -  
Current assets  
1    
 
43,956    
Prepayments and accrued income  
-    
 
-    
Creditors: amounts falling due within one year  
-    
 
( 17,213 )  
Net current assets (liabilities)  
  1  
 
  26,743  
Total assets less current liabilities  
  1  
 
  26,743  
Creditors: amounts falling due after more than one year  
  -  
 
  -  
Provisions for liabilities  
  -  
 
  -  
Accruals and deferred income  
  -  
 
  -  
Net assets  
  1  
 
  26,743  
   
Capital and reserves  
  1  
 
  26,743  

xbrli:pure 14402486 2023-08-03 2024-08-02 14402486 2022-10-06 2023-08-02 14402486 2024-08-02 14402486 2023-08-02 14402486 2023-08-03 14402486 uk-frs102:WithinOneYear 2024-08-02 14402486 uk-frs102:AfterOneYear 2024-08-02 14402486 uk-frs102:WithinOneYear 2023-08-02 14402486 uk-frs102:AfterOneYear 2023-08-02 14402486 uk-bus:AuditExempt-NoAccountantsReport 2023-08-03 2024-08-02 14402486 uk-bus:FilletedAccounts 2023-08-03 2024-08-02 14402486 uk-bus:Director1 1 2023-08-03 2024-08-02 14402486 uk-bus:Director1 2023-08-03 2024-08-02 14402486 uk-bus:Director1 1 2023-08-03 14402486 uk-bus:Director1 1 2024-08-02 14402486 uk-bus:Micro-entities 2023-08-03 2024-08-02 14402486 uk-bus:PrivateLimitedCompanyLtd 2023-08-03 2024-08-02 iso4217:GBP 14402486 countries:EnglandWales 2023-08-03 2024-08-02 14402486 uk-bus:RegisteredOffice 2023-08-03 2024-08-02

Footnotes to the Statement of Financial Position

Yousef Kassem

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 1.

3. Directors’ benefits: advances, credit and guarantees

Yousef Kassem

During the accounting year Yousef Kassem, a director of the company received an advance from the company that was repaid by 02/08/2024.

The following conditions are attached to advances payable by Yousef Kassem:

  • There is no interest due to be paid on any outstanding amount
  • No fixed date has been set for the amount to be repaid to the company.
Opening balance 03/08/2023 Additional advance Amount repaid Amount written off Amounts waived Interest payable Closing balance 02/08/2024
£ £ £ £ £ £ £
( 22,186 ) ( 4,715 )
( 4,715 )
26,901
26,901  
0 0 0 0  

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 02/08/2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 14402486

c) The company is a private company and is limited by shares

d) The company's registered office address is 20-22 Wenlock Road, London, N1 7GU, England

e) Company ceased to trade on 02/08/2023



Approved by the board of directors and signed on behalf of the board,

Urimpex Ltd
Director Yousef Kassem
Date of approval: 12/05/2025
The company was trading for the entire period 2023-08-03 2024-08-02 2024-08-02 Commercial analyst / consulting 2025-05-12 2025-05-12